Mathieu Klos - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Mathieu Klos's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Mathieu Klos

Mathieu Klos

Verified

Editor, Juve Patent

Cologne

Doesn’t Cover

gossip columns, food.

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 213

  • Janssen appeals to Supreme Court after Samsung Bioepis win in SPC waiver case

    By Mathieu Klos Verified| Juve Patent@ In February, the Dutch Court of Appeal under presiding judge J.I. de Vreese-Rood upheld a District Court judgment in PI proceedings between Janssen and Samsung Bioepis (case ID: 200.337.844/01). At the heart of the case was the interpretation of the EU regulation regarding the exemption for manufacturing pharmaceuticals for export to third countries, known as the SPC waiver. To date, European courts have seen little case law on this matter.

    By Mathieu Klos Verified · Juve Patent

    Apr. 18, 2025

  • Ones to Watch UK 2025: Edmund Eustace

    By Mathieu Klos Verified| Juve Patent@ Every year, JUVE Patent carries out extensive research in the UK patent market, culminating in the publication of the UK patent ranking. Our latest research highlighted Edmund Eustace, a barrister from 8 New Square as one of the current ‘Ones to Watch’ in the UK patent market. Edmund Eustace’s route to SEP litigation had been mapped out for several years.

    By Mathieu Klos Verified · Juve Patent

    Apr. 17, 2025

  • Janssen appeals to Supreme Court after Samsung Bioepis win in SPC waiver case

    By Mathieu Klos Verified| Juve Patent@ In February, the Dutch Court of Appeal under presiding judge J.I. de Vreese-Rood upheld a District Court judgment in PI proceedings between Janssen and Samsung Bioepis (case ID: 200.337.844/01). At the heart of the case was the interpretation of the EU regulation regarding the exemption for manufacturing pharmaceuticals for export to third countries, known as the SPC waiver. To date, European courts have seen little case law on this matter.

    By Mathieu Klos Verified · Juve Patent

    Apr. 18, 2025

As seen in

Company Info

Juve Patent

Cologne, North Rhine-Westphalia, Germany

+49 221 9138800